treatment guidelines

Research in Review

Patients With NSCLC Treated With Immunotherapy Likely to Respond to Chemo

05/09/2017

JCP Editors

Patients with advanced non-small cell lung cancer (NSCLC) who undergo salvage chemotherapy are 30% more likely to achieve partial response if they have been treated with a PD-1/PD-L1 checkpoint inhibitor, according...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

Older Patients With CLL Have Higher Risk of Disease-Related Mortality

05/04/2017

JCP Editors

Chronic lymphocytic leukemia (CLL)-related mortality is significantly higher in patients aged 75 years or older, prompting a need for novel treatment options, according to a study published in BMC Cancer...

...

05/04/2017

Journal of Clinical Pathways

Research in Review

Removing Metastases Improves Survival for Patients With Kidney Cancer

04/28/2017

JCP Editors

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse Large B-Cell Lymphoma

04/28/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large B-cell...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Bone Model Examines Treatment Effectiveness for Breast Cancer Metastases

04/24/2017

JCP Editors

A bone metastasis model has been created that simulates interactions between metastatic breast cancer cells and bone cells to determine effectiveness of different treatments, published in Nature Communications...

A bone...

04/24/2017

Journal of Clinical Pathways

Department

Cost-Effectiveness Analysis Reveals Optimal Immunotherapy for Metastatic NSCLC

04/12/2017

JCP Editors

Recent research suggests a particular immunotherapy may be less costly and offer time savings compared with nivolumab for patients with metastatic non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors,...

Recent...

04/12/2017

Journal of Clinical Pathways

Cancer, Other Chronic Conditions Underrepresented in Choosing Wisely Initiative

04/12/2017

JCP Editors

Few Choosing Wisely Initiative quality measures address issues pertaining to cancer and other serious chronic illness. ----- Related Content ASH’s Choosing Wisely Initiatives Choosing Wisely: Addressing the...

Few...

04/12/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy for MCL Improved by Targeted Drugs

04/10/2017

JCP Editors

Recent advances in targeted therapies have the potential for major impacts on treatment practices for mantle cell lymphoma (MCL), according to a recent review published in Pharmaceuticals...

Recent...

04/10/2017

Journal of Clinical Pathways

Research in Review

Rare Form of Colorectal Cancer Responds Well to Precision Medicine

04/06/2017

JCP Editors

Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...

...

04/06/2017

Journal of Clinical Pathways

Research in Review

Combined Treatment Approach Improves Survival for Patients With Glioblastoma

04/03/2017

JCP Editors

A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...

A...

04/03/2017

Journal of Clinical Pathways